SHH:600380
Joincare Pharmaceutical Group Industry Co.,Ltd. · SHH · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 13:38 UTC
Last close
n/aCNY
Market data
14.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
54.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
8.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
20.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.25Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.3%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Growth is the furthest below its sector's middle: 0.34 against 0.47 on the market's range.
Follow one yuan
lens 1 of 9After what it costs to make
62.4%
After running the business
22.8%
After interest and tax
8.8%
After what it must reinvest
20.5%
Kept after the dividend
17.6%
The five stops
5 of 5 read- After what it costs to make9,501,416,00062.4%
- After running the business3,465,929,00022.8%
- After interest and tax1,335,548,0008.8%
- After what it must reinvest3,124,644,64820.5%
- Kept after the dividend2,677,574,76217.6%
Of every unit of sales, 0.18 is still there after the dividend.
Of every unit of sales, 0.18 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales15,215,739,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it costs to make9,501,416,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After running the business3,465,929,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After interest and tax1,335,548,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it must reinvest3,124,644,648
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Kept after the dividend2,677,574,762
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY